https://mpra.ub.uni-muenchen.de/id/eprint/8144 2019-09-27T11:17:28Z info:eu-repo/semantics/descriptiveMetadata https://mpra.ub.uni-muenchen.de/8144/ Mergers and Acquisitions in the Indian Pharmaceutical Industry: Nature, Structure and Performance Beena, S L6 - Industry Studies: Manufacturing G34 - Mergers ; Acquisitions ; Restructuring ; Corporate Governance L80 - General This paper tries to address the extent, nature and impact of the recent surge in consolidation strategies especially in the form of mergers and acquisitions followed by the firms in the Indian pharmaceutical industry. The study found that many of the firms are implementing these strategies in the new context of globalisation mainly to overcome the acute competition arising out of the pro-market reforms and to strengthen their market portfolio. The study reaches the conclusion that the consolidation strategies followed by the firms enabled them to cut down the wasteful expenses to a greater extent and which resulted in better performance of the merging firms compared to the non-merging firms in this industry. 2006-06-28 MPRA Paper NonPeerReviewed application/pdf en https://mpra.ub.uni-muenchen.de/8144/1/MPRA_paper_8144.pdf Beena, S (2006): Mergers and Acquisitions in the Indian Pharmaceutical Industry: Nature, Structure and Performance. en info:eu-repo/semantics/objectFile info:eu-repo/semantics/humanStartPage